Trilogy Capital Portfolio holdings
Top Buys
Top Sells
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$40.7M |
| 2 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$36.2M |
| 3 |
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
|
+$17.5M |
| 4 |
Vanguard Mid-Cap ETF
VO
|
+$14.9M |
| 5 |
Vanguard Small-Cap ETF
VB
|
+$8.44M |
Sector Composition
| 1 | Financials | 1.18% |
| 2 | Technology | 0.63% |
| 3 | Consumer Staples | 0.45% |
| 4 | Consumer Discretionary | 0.42% |
| 5 | Healthcare | 0.29% |
Similar funds
Trilogy Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Trilogy Capital held 176 positions worth $1.33B, up 1.4% from $1.31B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Trilogy Capital withdrew a net $41.9M in Q4 2021, closing 11 positions and reducing 39 holdings. Its most notable exit was Vanguard Total International Stock ETF, an estimated $40.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 1.2% of assets, up from 1.1% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Trilogy Capital opened a new position in iShares Emerging Markets Equity Factor ETF worth $17.8M.
- Trilogy Capital's largest Q4 2021 buy was iShares Emerging Markets Equity Factor ETF: 347,512 shares worth $17.8M.
- Trilogy Capital added most to iShares Core Conservative Allocation ETF in Q4 2021, an estimated $34.5M increase.
- Trilogy Capital's biggest Q4 2021 reduction was iShares MSCI USA Momentum Factor ETF, cutting an estimated $36.2M.
- Trilogy Capital fully exited Vanguard Total International Stock ETF in Q4 2021, selling an estimated $40.7M.
- Trilogy Capital's ten largest holdings make up 44% of its $1.33B portfolio in Q4 2021.
- Trilogy Capital opened 24 new positions and closed 11 in Q4 2021.
- Trilogy Capital's portfolio value rose 1.4% quarter-over-quarter to $1.33B.
Based on Trilogy Capital's 13F filing for Q4 2021, filed 18 Jan 2022.